LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 125 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,000 | -42.9% | 1,043 | -53.5% | 0.00% | – |
| Q3 2019 | $7,000 | -50.0% | 2,245 | 0.0% | 0.00% | – |
| Q2 2019 | $14,000 | -58.8% | 2,245 | -63.9% | 0.00% | – |
| Q1 2019 | $34,000 | -17.1% | 6,211 | +2.7% | 0.00% | – |
| Q4 2018 | $41,000 | -39.7% | 6,048 | -5.0% | 0.00% | -100.0% |
| Q3 2018 | $68,000 | +19.3% | 6,365 | -3.9% | 0.00% | 0.0% |
| Q2 2018 | $57,000 | 0.0% | 6,623 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $57,000 | +5.6% | 6,623 | +21.2% | 0.00% | 0.0% |
| Q4 2017 | $54,000 | +315.4% | 5,464 | +419.4% | 0.00% | – |
| Q3 2017 | $13,000 | -72.3% | 1,052 | -63.5% | 0.00% | -100.0% |
| Q2 2017 | $47,000 | +213.3% | 2,880 | +172.7% | 0.00% | – |
| Q1 2017 | $15,000 | -21.1% | 1,056 | -22.1% | 0.00% | – |
| Q4 2016 | $19,000 | -20.8% | 1,356 | +0.2% | 0.00% | – |
| Q3 2016 | $24,000 | -11.1% | 1,353 | -29.2% | 0.00% | – |
| Q2 2016 | $27,000 | +17.4% | 1,910 | +0.7% | 0.00% | – |
| Q1 2016 | $23,000 | +27.8% | 1,896 | +36.8% | 0.00% | – |
| Q4 2015 | $18,000 | +63.6% | 1,386 | +38.6% | 0.00% | – |
| Q3 2015 | $11,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |